Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New triple-drug combo aims to extend life in hard-to-treat breast cancer

NCT ID NCT06889688

First seen May 12, 2026 · Last updated May 19, 2026 · Updated 3 times

Summary

This phase 3 trial tests whether a combination of three drugs (camrelizumab, apatinib, and eribulin) works better than standard chemotherapy for people with advanced triple-negative breast cancer. The study involves 246 participants and will measure how long the cancer stays under control and overall survival. The goal is to find a more effective treatment option for this aggressive cancer type.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER STAGE IV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Changhai Hospital of Shanghai

    RECRUITING

    Shanghai, China

    Contact Phone: •••-•••-••••

  • Sun Yat-sen Memorial Hospital

    RECRUITING

    Guangzhou, Guangdong, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Affiliated Hospital of Guizhou Medical University

    RECRUITING

    Guiyang, Guizhou, China

    Contact

    Contact Phone: •••-•••-••••

  • The Central Hospital Of Yong Zhou

    RECRUITING

    Yongzhou, Hunan, China

    Contact Phone: •••-•••-••••

    Contact

  • Wuhan Union Hospital of China

    NOT_YET_RECRUITING

    Wuhan, Hubei, China

    Contact

    Contact Phone: •••-•••-••••

  • Xiangya Hospital of Central South University

    NOT_YET_RECRUITING

    Changsha, Hunan, China

    Contact

    Contact Phone: •••-•••-••••

  • Yichang Central People's Hospital

    RECRUITING

    Yichang, Hubei, China

    Contact

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.